Cochrane · systematic review · CD002069
Calcium channel blockers for primary Raynaud's phenomenon
Ennis, H, Hughes, M, Anderson, ME, et al. · Cochrane Database of Systematic Reviews · 2016 · Cochrane Library
VascularAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
4
current version
GRADE rated
4
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 1 · 25%Low 1 · 25%Moderate 1 · 25%High 1 · 25%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Calcium channel blockers for primary Raynauds's phenomenon
Population: primary Raynaud's phenomenon
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Number of attacks | no estimate extracted | 7 studies · 296 participants | Moderate |
Duration of attacks | no estimate extracted | 1 study · 16 participants | Very low Downgraded: imprecision |
Severity scores | no estimate extracted | 6 studies · 291 participants | High |
Patient preference scores | no estimate extracted | 4 studies · 185 participants | Low |